APA citiranje

Liu, X., Zhang, Y., Li, K., Liu, Y., Xu, J., Ma, J., . . . Chu, X. (2021). A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma. Transl Oncol.

Citação norma Chicago

Liu, Xiaoqian, Yuanfeng Zhang, Kaimin Li, Yinghui Liu, Junqing Xu, Junjie Ma, Licai An, Hui Wang, and Xiaoxia Chu. "A Novel Dominant-negative PD-1 Armored Anti-CD19 CAR T Cell Is Safe and Effective against Refractory/relapsed B Cell Lymphoma." Transl Oncol 2021.

MLA citiranje

Liu, Xiaoqian, et al. "A Novel Dominant-negative PD-1 Armored Anti-CD19 CAR T Cell Is Safe and Effective against Refractory/relapsed B Cell Lymphoma." Transl Oncol 2021.